M Scheinowitz
Overview
Explore the profile of M Scheinowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Scheinowitz M, Kotlyar A, ZIMAND S, Ohad D, Leibovitz I, BLOOM N, et al.
Exp Physiol
. 1998 Oct;
83(5):585-93.
PMID: 9793779
Basic fibroblast growth factor (bFGF) is a potent mitogen which induces growth of collateral vessels in ischaemic and infarcted myocardium. The effect of systemically administered bFGF on left ventricular (LV)...
12.
Scheinowitz M, Abramov D, Kotlyar A, Savion N, Eldar M
Int J Cardiol
. 1998 May;
63(3):217-21.
PMID: 9578347
We examined the long-term effect of exogenous administration of bFGF and IGF-I on myocardial geometry in 72 Sprague-Dawley male rats subjected to AMI. A preloaded miniature osmotic pump subsequently implanted...
13.
Hasdai D, Barak V, Leibovitz E, Herz I, Sclarovsky S, Eldar M, et al.
Int J Cardiol
. 1997 Apr;
59(2):133-8.
PMID: 9158164
Background: Being a potent promoter of endothelial and smooth muscle cell proliferation, basic fibroblast growth factor (bFGF) is presumed to play a key role in coronary collateral development and atherogenesis....
14.
Scheinowitz M, Abramov D, Eldar M
Int J Cardiol
. 1997 Mar;
59(1):1-5.
PMID: 9080019
Current therapeutic techniques in acute myocardial infarction (AMI) are inadequate since restoration of blood flow through the obstructed coronary artery does not always preserve the ischemic myocardium. Therefore, deterioration of...
15.
Lazarous D, Shou M, Scheinowitz M, Hodge E, Thirumurti V, Kitsiou A, et al.
Circulation
. 1996 Sep;
94(5):1074-82.
PMID: 8790049
Background: We have shown that the angiogenic peptides basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) enhance canine coronary collateral development when administered for > or =...
16.
Hasdai D, Scheinowitz M, Leibovitz E, Sclarovsky S, Eldar M, Barak V
Heart
. 1996 Jul;
76(1):24-8.
PMID: 8774323
Objective: To assess serum interleukin-1 beta (IL-1 beta) concentrations in patients with ischaemic heart disease, to characterise subgroups of patients with raised IL-1 beta concentrations, and to examine whether serum...
17.
Greif H, Kreitler S, Kaplinsky E, Behar S, Scheinowitz M
Behav Med
. 1995 Jan;
21(2):75-85.
PMID: 8845579
Previous studies have shown that cardiovascular patients benefit from exercise. The explanations are partly physical and partly psychological, yet evidence for the latter is contradictory, possibly because only selected samples...
18.
Lazarous D, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, et al.
Circulation
. 1995 Jan;
91(1):145-53.
PMID: 7805195
Background: Recently we reported that intracoronary administration of basic fibroblast growth factor (bFGF), a potent angiogenic peptide, increases collateral blood flow in dogs subjected to progressive left circumflex coronary artery...
19.
Scheinowitz M, Shou M, Banai S, Gertz S, Lazarous D, Unger E
Lab Invest
. 1994 Dec;
71(6):813-9.
PMID: 7632203
Background: A number of experimental preparations have been used to elucidate the pathophysiology of restenosis after percutaneous transluminal coronary angioplasty; however, few models have been advanced that address restenosis in...
20.
Inbar O, Oren A, Scheinowitz M, Rotstein A, Dlin R, Casaburi R
Med Sci Sports Exerc
. 1994 May;
26(5):538-46.
PMID: 8007799
Healthy men (N = 1424, age 20-70 yr) underwent a progressive incremental treadmill exercise test to volitional maximum. Cardiopulmonary variables were measured breath-by-breath. The aerobic power (VO2max) declined at an...